A prospective study on radiofrequency ablation locally advanced pancreatic cancer

Hepatobiliary and Pancreatic Diseases International

Volumn 9, Issue 3, 2010, Pages 306-311

  Casadei, Riccardo ^a   Ricci, Claudio ^a   Pezzilli, Raffaele ^a   Serra, Carla ^a   Calculli, Lucia ^a   Morselli Labate, Antonio Maria ^a   Santini, Donatella ^b   Minni, Francesco ^a  

^a Department of Surgery ^*  (United States)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Efficacy; Pancreatic neoplasms; Radiofrequency ablation; Safety; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ANALGESIA; ARTICLE; ASCITES; BILE DUCT BYPASS; BILE DUCT FISTULA; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FEMALE; GASTROJEJUNOSTOMY; GROUPS BY AGE; HUMAN; MALE; MORBIDITY; MULTIMODALITY CANCER THERAPY; PANCREAS CANCER; PERFORMANCE; PROSPECTIVE STUDY; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; SURGICAL MORTALITY; SURVIVAL TIME; ADENOCARCINOMA; BILIARY FISTULA; CATHETER ABLATION; JEJUNOSTOMY; MIDDLE AGED; MORTALITY; PAIN, POSTOPERATIVE; PANCREAS RESECTION; PANCREATIC NEOPLASMS; PATHOLOGY; STOMACH BYPASS; TIME; TREATMENT OUTCOME; TUMOR INVASION; VERY ELDERLY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ASCITES; BILIARY FISTULA; CATHETER ABLATION; FEMALE; GASTRIC BYPASS; HUMANS; JEJUNOSTOMY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PAIN, POSTOPERATIVE; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; QUALITY OF LIFE; TIME FACTORS; TREATMENT OUTCOME;

EID: 77953853366     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Brennan MF, Kattan MW, Klimstra D, Conlon K. Prognosticnomogram for patients undergoing resection for adenocarcinomaof the pancreas. Ann Surg 2004;240:293-298.
2. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. NEngl J Med 2004;350:1200-1210.
3. Verslype C, Van Cutsem E, Dicato M, Cascinu S, Cunningham D, Diaz-Rubio E, et al. The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006. Ann Oncol 2007;18:vii1-10.
4. Smeenk HG, Incrocci L, Kazemier G, van Dekken H, Tran KT, Jeekel J, et al. Adjuvant 5-FU-based chemoradiotherapy for patients undergoing R-1/R-2 resections for pancreatic cancer. Dig Surg 2005;22:321-328.
5. Yip D, Karapetis C, Strickland A, Steer CB, Goldstein D. Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer. Cochrane Database Syst Rev 2006;3: CD002093.
6. Andersen JR, Sorensen SM, Kruse A, Rokkjaer M, Matzen P. Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut 1989;30:1132-1135.
7. Shepherd HA, Royle G, Ross AP, Diba A, Arthur M, Colin-Jones D. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br J Surg 1988;75:1166-1168.
8. Smith AC, Dowsett JF, Russell RC, Hatfield AR, Cotton PB. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction. Lancet 1994; 344:1655-1660.
9. Jeurnink SM, van Eijck CH, Steyerberg EW, Kuipers EJ, Siersema PD. Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: a systematic review. BMC Gastroenterol 2007;7:18.
10. Lillemoe KD, Cameron JL, Hardacre JM, Sohn TA, Sauter PK, Coleman J, et al. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 1999;230:322-330.
11. Jansen MC, van Hillegersberg R, Chamuleau RA, van Delden OM, Gouma DJ, van Gulik TM. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review. Eur J Surg Oncol 2005;31:331-347.
12. Simon CJ, Dupuy DE. Current role of image-guided ablative therapies in lung cancer. Expert Rev Anticancer Ther 2005;5: 657-666.
13. Singletary ES. Feasibility of radiofrequency ablation for primary breast cancer. Breast Cancer 2003;10:4-9.
14. Boss A, Clasen S, Kuczyk M, Anastasiadis A, Schmidt D, Graf H, et al. Magnetic resonance-guided percutaneous radiofrequency ablation of renal cell carcinomas: a pilot clinical study. Invest Radiol 2005;40:583-590.
15. Wood BJ, Abraham J, Hvizda JL, Alexander HR, Fojo T. Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases. Cancer 2003;97:554-560.
16. Shariat SF, Raptidis G, Masatoschi M, Bergamaschi F, Slawin KM. Pilot study of radiofrequency interstitial tumor ablation (RITA) for the treatment of radio-recurrent prostate cancer. Prostate 2005;65:260-267.
17. Martel J, Bueno A, Ortiz E. Percutaneous radiofrequency treatment of osteoid osteoma using cool-tip electrodes. Eur J Radiol 2005;56:403-408.
18. Chiou YY, Hwang JI, Chou YH, Wang HK, Chiang JH, Chang CY. Percutaneous ultrasound-guided radiofrequency ablation of intrahepatic cholangiocarcinoma. Kaohsiung J Med Sci 2005;21:304-309.
19. Siriwardena AK. Radiofrequency ablation for locally advanced cancer of the pancreas. JOP 2006;7:1-4.
20. Pezzilli R, Ricci C, Casadei R, Serra C, Calculli L, Antonacci N, et al Radiofrequency ablation of pancreatic cancer: a new attractive approach or another unsuccessful technique for the treatment of pancreatic adenocarcinoma? Cancer Therapy 2008;6:741-744.
21. Calculli L, Casadei R, Amore B, Albini Riccioli L, Minni F, Caputo M, et al. The usefulness of spiral Computed Tomography and colour-Doppler ultrasonography to predict portal-mesenteric trunk involvement in pancreatic cancer. Radiol Med 2002;104:307-315.
22. Date RS, Biggins J, Paterson I, Denton J, McMahon RF, Siriwardena AK. Development and validation of an experimental model for the assessment of radiofrequency ablation of pancreatic parenchyma. Pancreas 2005;30:266-271.
23. Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005;138:8-13.
24. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-655.
25. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-376.
26. Daut RL, Cleeland CS, Flanery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 1983;17:197-210.
27. Spiliotis JD, Datsis AC, Michalopoulos NV, Kekelos SP, Vaxevanidou A, Rogdakis AG, et al. Radiofrequency ablation combined with palliative surgery may prolong survival of patients with advanced cancer of the pancreas. Langenbecks Arch Surg 2007;392:55-60.
28. Pezzilli R, Casadei R, Calculli L, Santini D, Morselli Labate AM, on behalf of NeoPan Study Group. The Sant Orsola Algorithm for pancreatic cancer: an interim report. JOP 2006;7:546.
29. Dupont WD and Plummer WD. PS power and sample size program available for free on the Internet. Controlled Clin Trials.1997;18:274.
30. Date RS, Siriwardena AK. Radiofrequency ablation of the pancreas. II: Intra-operative ablation of non-resectable pancreatic cancer. A description of technique and initial outcome. JOP 2005;6:588-592.
31. Mornex F, Girard N, Delpero JR, Partensky C. Radiochemotherapy in the management of pancreatic cancer--part I: neoadjuvant treatment. Semin Radiat Oncol 2005;15:226-234.
32. Matsui Y, Nakagawa A, Kamiyama Y, Yamamoto K, Kubo N, Nakase Y. Selective thermocoagulation of unresectable pancreatic cancers by using radiofrequency capacitive heating. Pancreas 2000;20:14-20.
33. Tang Z, Wu YL, Fang HQ, Xu J, Mo GQ, Chen XM, et al. Treatment of unresectable pancreatic carcinoma by radiofrequency ablation with 'cool-tip needle': report of 18 cases. Zhonghua Yi Xue Za Zhi 2008;88:391-394.
34. Elias D, Baton O, Sideris L, Lasser P, Pocard M. Necrotizing pancreatitis after radiofrequency destruction of pancreatic tumours. Eur J Surg Oncol 2004;30:85-87.
35. Koninger J, Wente MN, Müller MW, Gutt CN, Friess H, Büchler MW. Surgical palliation in patients with pancreatic cancer. Langenbecks Arch Surg 2007;392:13-21.
36. Varshney S, Sewkani A, Sharma S, Kapoor S, Naik S, Sharma A, et al. Radiofrequency ablation of unresectable pancreatic carcinoma: feasibility, efficacy and safety. JOP 2006;7:74-78.
37. Nishida K, Kaneko T, Yoneda M, Nakagawa S, Ishikawa T, Yamane E, et al. Doubling time of serum CA 19-9 in the clinical course of patients with pancreatic cancer and its significant association with prognosis. J Surg Oncol 1999;71: 140-146.